Loblaw Companies Limited · TSX:L
Loblaw Companies — Q4 2023 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, February 2024
Slide 1: Supplementary Slides Q4 2023
SUPPLEMENTARY SLIDES Q4 2023 For the periods ended December 30, 2023 and December 31, 2022 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q4 2023 (millions of Canadian dollars unless otherwise noted) Q4 2023 Q4 2022 % Change (1) Consolidated Revenue $14,531 $14,007 ↑ +3.7% Adjusted EBITDA $1,633 $1,493 ↑ +9.4% Adjusted EBITDA Margin 11.2 % 10.7 % ↑ 50bps Adjusted Net Earnings Avaliable to Common Sh
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q4 2023 (millions of Canadian dollars unless otherwise noted) Q4 2023 Q4 2022 % Change (1) Total Retail Revenue $14,157 $13,694 ↑ 3.4% Retail Revenue - Food $9,774 $9,514 ↑ 2.7% Retail Revenue - Drug $4,383 $4,180 ↑ 4.9% Pharmacy and Healthcare Services $2,099
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q4 2023 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +2.0% Basket Size(2) ↓ Traffic(2) ↑ Loblaw STM Square Footage Growth ≈ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +4.6